{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:42:08Z","timestamp":1780544528940,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010888","name":"Wuhan Municipal Science and Technology Innovation Bureau","doi-asserted-by":"publisher","award":["2025020602030105"],"award-info":[{"award-number":["2025020602030105"]}],"id":[{"id":"10.13039\/501100010888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018806","name":"Department of Science and Technology of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijbiomac.2026.151813","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:07:57Z","timestamp":1775135277000},"page":"151813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design of binder proteins specific to IL-13"],"prefix":"10.1016","volume":"358","author":[{"given":"Yang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banbin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151813_bb0005","doi-asserted-by":"crossref","DOI":"10.1067\/mai.2003.1333","article-title":"IL-13 receptors and signaling pathways: an evolving web","volume":"111","author":"Hershey","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.151813_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.immunol.21.120601.141142","article-title":"IL-13 effector functions","volume":"21","author":"Wynn","year":"2003","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151813_bb0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2015.05.023","article-title":"Commentary: IL-4 and IL-13 receptors and signaling","volume":"75","author":"McCormick","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151813_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ni1544","article-title":"Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain","volume":"9","author":"Ramalingam","year":"2008","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151813_bb0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151813_bb0030","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1165\/rcmb.2006-0180OC","article-title":"IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production","volume":"36","author":"Zhen","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151813_bb0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/all.13954","article-title":"Interleukin-13: Targeting an underestimated cytokine in atopic dermatitis","volume":"75","author":"Bieber","year":"2020","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151813_bb0040","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s13555-023-00947-7","article-title":"Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab","volume":"13","author":"Okragly","year":"2023","journal-title":"Dermatol. Ther. (Heidelb.)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151813_bb0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2018.05.029","article-title":"Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151813_bb0050","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/thoraxjnl-2014-206719","article-title":"Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies","volume":"70","author":"Hanania","year":"2015","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151813_bb0055","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/bjd.21867","article-title":"Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials","volume":"187","author":"Simpson","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijbiomac.2026.151813_bb0060","doi-asserted-by":"crossref","first-page":"1458438","DOI":"10.3389\/fphar.2024.1458438","article-title":"Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data","volume":"15","author":"Zhao","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151813_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13223-021-00574-x","article-title":"Transcutaneous penetration of a single-chain variable fragment (scFv) compared to a full-size antibody: potential tool for atopic dermatitis (AD) treatment","volume":"17","author":"Baylet","year":"2021","journal-title":"Allergy, Asthma Clin. Immunol."},{"issue":"7976","key":"10.1016\/j.ijbiomac.2026.151813_bb0070","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature"},{"issue":"7910","key":"10.1016\/j.ijbiomac.2026.151813_bb0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41586-022-04654-9","article-title":"Design of protein-binding proteins from the target structure alone","volume":"605","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151813_bb0080","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jmb.2016.12.005","article-title":"Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13R\u03b11 and IL-13R\u03b12","volume":"429","author":"Popovic","year":"2017","journal-title":"J. Mol. Biol."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2026.151813_bb0085","article-title":"Minibinders targeting Staphylococcus aureus \u03b1-toxin exert protective effects in vivo","volume":"319","author":"Weng","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"7738","key":"10.1016\/j.ijbiomac.2026.151813_bb0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41586-018-0830-7","article-title":"De novo design of potent and selective mimics of IL-2 and IL-15","volume":"565","author":"Silva","year":"2019","journal-title":"Nature"},{"issue":"7674","key":"10.1016\/j.ijbiomac.2026.151813_bb0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature23912","article-title":"Massively parallel de novo protein design for targeted therapeutics","volume":"550","author":"Chevalier","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.151813_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151813_bb0105","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151813_bb0110","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2026.151813_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139403","article-title":"Design of minibinder proteins specific to TNFR1","volume":"293","author":"Weng","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151813_bb0120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcp.1041400219","article-title":"Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin","volume":"140","author":"Kitamura","year":"1989","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151813_bb0125","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.molimm.2005.11.001","article-title":"Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1","volume":"43","author":"Krause","year":"2006","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151813_bb0130","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151813_bb0135","first-page":"L478","article-title":"Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation","volume":"289","author":"Abonyo","year":"2005","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151813_bb0140","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.4049\/jimmunol.171.11.5901","article-title":"IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site","volume":"171","author":"Hebenstreit","year":"2003","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151813_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/BJ20121819","article-title":"Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor \u03b11","volume":"451","author":"Redpath","year":"2013","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151813_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The Therapeutic Potential of Nanobodies","volume":"34","author":"Jov\u010devska","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.ijbiomac.2026.151813_bb0155","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2147\/IJN.S297631","article-title":"Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy","volume":"16","author":"Sun","year":"2021","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151813_bb0160","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The Cytokines of Asthma","volume":"50","author":"Lambrecht","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151813_bb0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd4624","article-title":"Targeting key proximal drivers of type 2 inflammation in disease","volume":"15","author":"Gandhi","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"32","key":"10.1016\/j.ijbiomac.2026.151813_bb0170","doi-asserted-by":"crossref","first-page":"22172","DOI":"10.1074\/jbc.M114.570143","article-title":"A cleavage-potentiated fragment of tear lacritin is bactericidal","volume":"289","author":"McKown","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.151813_bb0175","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/j.cell.2024.05.052","article-title":"Preclinical proof of principle for orally delivered Th17 antagonist miniproteins","volume":"187","author":"Berger","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151813_bb0180","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/mabs.2.3.11641","article-title":"The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions","volume":"2","author":"Harding","year":"2010","journal-title":"MAbs"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151813_bb0185","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.clim.2013.09.006","article-title":"T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation","volume":"149","author":"Jawa","year":"2013","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151813_bb0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/vde.12935","article-title":"Clinical signs and diagnosis of feline atopic syndrome: detailed guidelines for a correct diagnosis","volume":"32","author":"Santoro","year":"2021","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.ijbiomac.2026.151813_bb0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12890-015-0097-9","article-title":"Dynamics of IL-4 and IL-13 expression in the airways of sheep following allergen challenge","volume":"15","author":"Liravi","year":"2015","journal-title":"BMC Pulm. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151813_bb0200","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1292\/jvms.20-0301","article-title":"Association analysis of non-synonymous polymorphisms of interleukin-4 receptor-\u03b1 and interleukin-13 genes in canine atopic dermatitis","volume":"82","author":"Tanaka","year":"2020","journal-title":"J. Vet. Med. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151813_bb0205","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cell.2007.12.030","article-title":"Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4\/13 system","volume":"132","author":"LaPorte","year":"2008","journal-title":"Cell"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026017393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026017393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:09:45Z","timestamp":1776150585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026017393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"alternative-id":["S0141813026017393"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151813","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of binder proteins specific to IL-13","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151813"}}